Takeda’s Strategic Focus on Gastroenterology Treatments and Rare Diseases Positions them for Growth
The Japanese pharmaceutical company Takeda has in its company strategy bet on the treatments of gastroenterology, and attend diseases rare such as hemophilia, oncology and vaccinesbecause it considers that this is where their innovation is required and with it they can grow. In interview with MILLENNIUMHernán Porcille, general director of the firm in Mexico, explained … Read more